What were Chemours' second-quarter 2023 revenue and net loss figures, and how did they compare year-over-year?

Chemours reported second-quarter total sales of $1.591 billion, representing a 1% year-over-year decline. The company reported a GAAP net loss attributable to shareholders of $274 million, or $1.81 per diluted share, an improvement from the $380 million net loss in the same period last year. While revenue declined slightly, the company offset lower shipment volumes with price increases across business segments.

How did Chemours' adjusted profitability and cash flow perform in Q2 2023, and what was cited as the main pressure point on results?

On an adjusted basis, Chemours achieved net income of $64 million ($0.42 per share), meeting institutional expectations, and adjusted EBITDA of $247 million. Free cash flow surged 128% year-over-year, and the debt leverage ratio decreased to 4.4x. The primary headwind cited was lower global sales volume of low-global-warming-potential Opteon refrigerants.

Chemours Revenue Slightly Declines

Aug 10, 2026

Chemours Q2 sales fell 1% to $1.591 billion amid lower Opteon refrigerant demand, though adjusted net profit reached $64 million meeting analyst expectations with free cash flow up 128%.

ccin

2026-04-17

Chemours' Fayetteville Works Earns Gold-Level WHC Conservation Certification for Environmental Excellence

2026-04-18

Chemours Company Receives Average 'Hold' Recommendation from Brokerages

2026-04-21

Chemours' West Virginia Forest Partnership Delivers Measurable Climate and Community Impact After Five Years

2026-04-21

Chemours to Release Q1 2026 Results May 5, Host Webcast

2026-04-22

Activists Demand No-Mining Pledge Near Okefenokee Swamp from Chemours